Trade Court Ruling Invalidates Trumps 10 Blanket Tariffs
Besset Predicts Substantial Disinflation as Fed Leadership Transitions to Warsh
UK Exports to US Plunge 25 Following Trumps Liberation Day Tariff Blitz
New York Times Pips Puzzle Game Expands Digital Offerings Potential for Subscriber Engagement Growth
Slow Food Founder Carlo Petrini Passes Away at 76 Implications for the Sustainable Food Movement
Indias Job Engine Strains as Iran Conflict Hits Remittances and Trade
CACC Q1 2026 Earnings EPS Slightly Misses Estimates Amid Subprime Auto Lending Landscape
TGEN Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher
RERE Q1 2026 Earnings EPS Crushes Estimates by Over 700 on Operational Strength
WPC Q1 2026 Earnings EPS Surges Past Estimates Despite Slight Stock Decline
INSP Q1 2026 Earnings EPS Misses Estimates by 376 Stock Edges Higher
FMAO Q1 2026 Earnings EPS Surpasses Estimates by 38 Amid Steady Operations
Costamare Inc CMRE Shares Slide Over 4 Key Support Levels in Focus
GigCapital9 Corp Units GIXXU Holds Steady at 1018 Amid Low Volatility
Ovintiv Inc OVV Shows Resilience with Modest Uptick Holds Near Key Support
Linde LIN Slips 12 as Defensive Positioning Wavers Key Support in Focus
Climb Global Solutions Inc CLMB Gains Ground Testing Key Resistance at 22
Standard Chartered to Cut Over 15 of Corporate Roles in Efficiency Drive
Simulations Plus SLP Q1 2026 Earnings Earnings Beat Drives Positive Market Reaction
Park Ha Biological Technology BYAH Holds Gains as Stock Tests Key Support Zone
Birchtech Corp BCHT Q1 2026 Earnings WiderThanExpected Loss but Positive Market Reaction
A2Z Cust2Mate Solutions Corp AZ Q3 2025 Earnings Loss Per Share of 007 as Company Continues Platform Investments Stock Moves Higher
SPOT Q1 2026 Earnings EPS Beats Estimates by 1445 as Stock Surges 611
OCS Q1 2026 Earnings WiderthanExpected Loss Weighs on Stock
ARLP Q1 2026 Earnings Modest EPS Beat Amid Flat Revenue Disclosure
BUSEP Q1 2026 Earnings EPS Surges Past Estimates Stock Rises Modestly
ELTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Advances Pipeline Without Revenue